You are here

  • Home
  • Archive
  • Volume 71, Issue 8
  • Nasal high flow oxygen therapy in patients with COPD reduces respiratory rate and tissue carbon dioxide while increasing tidal and end-expiratory lung volumes: a randomised crossover trial

Article info

Article menu
Research letter
Nasal high flow oxygen therapy in patients with COPD reduces respiratory rate and tissue carbon dioxide while increasing tidal and end-expiratory lung volumes: a randomised crossover trial

Authors

  • John F Fraser Critical Care Research Group, The Prince Charles Hospital and University of Queensland, Brisbane, Australia PubMed articlesGoogle scholar articles
  • Amy J Spooner Critical Care Research Group, The Prince Charles Hospital and University of Queensland, Brisbane, Australia PubMed articlesGoogle scholar articles
  • Kimble R Dunster Critical Care Research Group, The Prince Charles Hospital and University of Queensland, Brisbane, Australia Biomedical Engineering and Medical Physics, Science and Engineering Faculty, Queensland University of Technology, Brisbane, Australia PubMed articlesGoogle scholar articles
  • Chris M Anstey Critical Care Research Group, The Prince Charles Hospital and University of Queensland, Brisbane, Australia Intensive Care Unit, Nambour General Hospital, Nambour, Australia PubMed articlesGoogle scholar articles
  • Amanda Corley Critical Care Research Group, The Prince Charles Hospital and University of Queensland, Brisbane, Australia PubMed articlesGoogle scholar articles
  1. Correspondence to Amanda Corley, Critical Care Research Group, Level 5 CSB, The Prince Charles Hospital, Rode Rd, Chermside, Brisbane, QLD 4032, Australia; amanda.corley{at}health.qld.gov.au
View Full Text

Citation

Fraser JF, Spooner AJ, Dunster KR, et al
Nasal high flow oxygen therapy in patients with COPD reduces respiratory rate and tissue carbon dioxide while increasing tidal and end-expiratory lung volumes: a randomised crossover trial
Thorax 2016;71:759-761.

Publication history

  • Received October 18, 2015
  • Revised February 22, 2016
  • Accepted February 26, 2016
  • First published March 25, 2016.
Online issue publication 
September 01, 2022

Article Versions

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/ This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/